Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000886163-22-000120
Filing Date
2022-08-10
Accepted
2022-08-10 16:05:41
Documents
5
Effectiveness Date
2022-08-10

Document Format Files

Seq Description Document Type Size
1 S-8 ligand-formsx8_8102022.htm S-8 124096
2 EX-FILING FEES exhibit107_8102022.htm EX-FILING FEES 24665
3 EX-5.1 s-8_exhibit51x8102022.htm EX-5.1 9826
4 EX-23.1 s-8_exhibit231x8102022.htm EX-23.1 2466
5 lwheader.jpg GRAPHIC 54167
  Complete submission text file 0000886163-22-000120.txt   231343
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

EIN.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-266737 | Film No.: 221151804
SIC: 2834 Pharmaceutical Preparations